PURPOSE: To report the clinical features and epidemiology of uveal melanoma in Ireland. METHODS: This was an observational study of 253 patients with a new diagnosis of uveal melanoma between June 2010 and December 2015. Main outcome measures included demographics, clinical features, age-adjusted incidence, relative survival, overall survival, and distant metastases-free survival. RESULTS: The mean patient age was 61.7 years. Tumour location was choroidal in 82%, ciliochoroidal in 9%, iridociliary in 2%, and iris in 7%. Treatment modalities included brachytherapy (ruthenium-106 and iodine-125 [64%]), enucleation (27%), and proton beam radiation (8%). The mean age-adjusted incidence of uveal melanoma in Ireland from 2010 to 2015 was 9.5 per million of the population (95% confidence interval [CI]: 8.4-10.7). Four-year relative survival was 81.3% (95% CI: 72.8-87.3). Four-year overall survival was 84% (95% CI: 78-90) and 4-year distant metastases-free survival was 79% (95% CI: 73-86). CONCLUSION: Based on this data, the incidence of uveal melanoma in Ireland is high when compared with other reported incidence rates in Europe and worldwide. Relative and observed survival were in keeping with other reported European survival rates.
PURPOSE: To report the clinical features and epidemiology of uveal melanoma in Ireland. METHODS: This was an observational study of 253 patients with a new diagnosis of uveal melanoma between June 2010 and December 2015. Main outcome measures included demographics, clinical features, age-adjusted incidence, relative survival, overall survival, and distant metastases-free survival. RESULTS: The mean patient age was 61.7 years. Tumour location was choroidal in 82%, ciliochoroidal in 9%, iridociliary in 2%, and iris in 7%. Treatment modalities included brachytherapy (ruthenium-106 and iodine-125 [64%]), enucleation (27%), and proton beam radiation (8%). The mean age-adjusted incidence of uveal melanoma in Ireland from 2010 to 2015 was 9.5 per million of the population (95% confidence interval [CI]: 8.4-10.7). Four-year relative survival was 81.3% (95% CI: 72.8-87.3). Four-year overall survival was 84% (95% CI: 78-90) and 4-year distant metastases-free survival was 79% (95% CI: 73-86). CONCLUSION: Based on this data, the incidence of uveal melanoma in Ireland is high when compared with other reported incidence rates in Europe and worldwide. Relative and observed survival were in keeping with other reported European survival rates.
Authors: P Guénel; L Laforest; D Cyr; J Févotte; S Sabroe; C Dufour; J M Lutz; E Lynge Journal: Cancer Causes Control Date: 2001-06 Impact factor: 2.506
Authors: Claire M Vajdic; Anne Kricker; Michael Giblin; John McKenzie; Joanne Aitken; Graham G Giles; Bruce K Armstrong Journal: Int J Cancer Date: 2002-09-10 Impact factor: 7.396
Authors: Frank Tschentscher; Johannes Hüsing; Tanja Hölter; Elisabeth Kruse; Irina Gana Dresen; Karl-Heinz Jöckel; Gerasimos Anastassiou; Harald Schilling; Norbert Bornfeld; Bernhard Horsthemke; Dietmar Rudolf Lohmann; Michael Zeschnigk Journal: Cancer Res Date: 2003-05-15 Impact factor: 12.701
Authors: R Folberg; J Pe'er; L M Gruman; R F Woolson; G Jeng; P R Montague; T O Moninger; H Yi; K C Moore Journal: Hum Pathol Date: 1992-11 Impact factor: 3.466
Authors: Annemijn P A Wierenga; Gülçin Gezgin; Els van Beelen; Michael Eikmans; Marijke Spruyt-Gerritse; Niels J Brouwer; Mieke Versluis; Robert M Verdijk; Sjoerd G van Duinen; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager Journal: Cancers (Basel) Date: 2019-08-18 Impact factor: 6.639
Authors: Elias A T Koch; Anne Petzold; Anja Wessely; Edgar Dippel; Michael Erdmann; Lucie Heinzerling; Bettina Hohberger; Harald Knorr; Ulrike Leiter; Friedegund Meier; Peter Mohr; Farnaz Rahimi; Beatrice Schell; Max Schlaak; Patrick Terheyden; Beatrice Schuler-Thurner; Selma Ugurel; Jochen Utikal; Julio Vera; Michael Weichenthal; Fabian Ziller; Carola Berking; Markus V Heppt Journal: Cancer Immunol Immunother Date: 2021-10-28 Impact factor: 6.630
Authors: Laurien E Houtzagers; Annemijn P A Wierenga; Aleid A M Ruys; Gregorius P M Luyten; Martine J Jager Journal: Int J Mol Sci Date: 2020-09-28 Impact factor: 5.923